Tanvir Pharma India Private Limited
About Tanvir Pharma India Private Limited
Data last updated:
Tanvir Pharma India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52311DL2013PTC249799. Its GSTIN is 09AAECT5673R1ZD (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Lukman Malik and Shadab Ahmed.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H – 11 Abul Fazal Enclave Okhla, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.07 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹43,000 (net margin 0.4%) and EBITDA of ₹1.22 Lakh (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Tanvir Pharma India Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH – 11 Abul Fazal Enclave Okhla, New Delhi, Delhi, India – 110025
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tanvir Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tanvir Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tanvir Pharma India Private Limited, buy the company report.
Financials of Tanvir Pharma India Private Limited
FY 2024 filings availableTanvir Pharma India Private Limited reported revenue of ₹1.07 Cr (down 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹43,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tanvir Pharma India Private Limited, buy the company report.
Board of directors of Tanvir Pharma India Private Limited
Tanvir Pharma India has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lukman Malik | Director | 15 Mar 2017 | 9 Years 7 Months | Current |
| Shadab Ahmed | Director | 25 Mar 2013 | 13 Years 7 Months | Current |
| Kamran Khan | Director | 29 Nov 2024 | 1 Years 11 Months | Current |
Peer comparison
Tanvir Pharma India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Furies Health Care Private Limited | ₹1.08 Cr (FY 2025) | -16.0% | Bongaigaon, Assam, India | |||
| Sioux K Healthcare (India) Private Limited | ₹1.08 Cr (FY 2025) | 17.0% | Jaipur, Rajasthan, India | |||
| Health Essentials (India) Private Limited | ₹1.07 Cr (FY 2020) | -44.0% | Hyderabad, Telangana, India | |||
| Tanvir Pharma India Private Limitedthis company | ₹1.07 Cr (FY 2024) | ₹43,000 | 0.4% | -15.0% | New Delhi, Delhi, India | |
| Clinical Sleep and Respiratory Solutions Private Limited | ₹1.06 Cr (FY 2024) | -3.0% | Bangalore, Karnataka, India | |||
| Jaft Biotech Private Limited | ₹1.06 Cr (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| Vetlink Pharma Private Limited | ₹1.06 Cr (FY 2025) | 0.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Tanvir Pharma India Private Limited, buy the company report.
Auditor
Tanvir Pharma India Private Limited is audited by A S A G & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A S A G & ASSOCIATES | FY 2020 | 020208C |
Shareholding
The shareholding of Tanvir Pharma India Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Tanvir Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Tanvir Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tanvir Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tanvir Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECT5673R1ZD | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Tanvir Pharma India Private Limited, buy the company report.
Recent activity
Tanvir Pharma India Private Limited has 6 board changes on record since 2013: 4 appointments and 2 cessations. The latest: Kamran Khan was appointed as Director on 29 Nov 2024.
Frequently asked questions
Tanvir Pharma India is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 March 2013 (13+ years old) and is registered under CIN U52311DL2013PTC249799.
Tanvir Pharma India has 3 current directors:
- Lukman Malik - Director
- Shadab Ahmed - Director
- Kamran Khan - Director
The latest financial statements of Tanvir Pharma India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Tanvir Pharma India is 09AAECT5673R1ZD, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Tanvir Pharma India is U52311DL2013PTC249799. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tanvir Pharma India was incorporated on 25 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Tanvir Pharma India by revenue are Furies Health Care Private Limited, Sioux K Healthcare (India) Private Limited, Health Essentials (India) Private Limited, Clinical Sleep and Respiratory Solutions Private Limited, Jaft Biotech Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kamran Khan was appointed as Director on 29 Nov 2024. Shadab Ahmed ceased to be Director on 15 Jan 2021. Lukman Malik was appointed as Director on 15 Mar 2017. Tanvir Pharma India has 6 board changes on record in total.
The registered office of Tanvir Pharma India is at H – 11 Abul Fazal Enclave Okhla, New Delhi, Delhi, India – 110025.
Tanvir Pharma India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Tanvir Pharma India is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
